Ivantis To Pay $60M To End Patent Fight Over Glaucoma Tech
Glaukos Corp. and Ivantis Inc. have inked a $60 million deal to end their patent dispute over therapies for treating glaucoma, the companies announced Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article